Checkpoint Surgical today announced the results of a study that called its handheld nerve monitor a safe and reliable alternative to existing technology for neural monitoring during surgery. The retrospective study compared the use of the Cleveland, Ohio-based company’s Checkpoint nerve stimulator/locator to Medtronic’s nerve integrity monitor for vagal, recurrent and superior laryngeal nerve monitoring […]
Checkpoint Surgical said today that it raised another $9 million for the handheld nerve monitor it’s developing. The Cleveland-based company said the $8.8 million round was led by Mutual Capital Partners and included prior backers First Analysis, the JumpStart NEXT Fund and several individual investors. Checkpoint said it plans to use the proceeds to build out its sales […]
Neuroprotective device maker Checkpoint Surgical said it closed its 1st round of institutional financing, bringing in $7.5 million for its Checkpoint handheld nerve monitor. The Checkpoint Stimulator/Locater stimulates motor nerves so surgeons can avoid damaging them during surgery. The device also helps physicians gauge nerve and muscle health. The device has been on the U.S. market since […]
Checkpoint Surgical is looking for another $2.5 million to cap off a $10 million equity funding round originally launched in 2011, according to the company’s SEC documents.
The market for hip and knee implants is stable but mired in a low-growth stage, according to analysts who attended the American Academy of Orthopedic Surgeons conference in San Francisco last week.
Although the abrupt departure of Stryker CEO Steve MacMillan drew the lion’s share of attention at the AAOS event, analysts from Barclays Capital and Leerink Swann agreed that the sector’s outlook calls for low-single-digit growth.
iRobot Corp. (NSDQ: IRBT), famous for their Roomba automated cleaning robots, invested $6 million and launched an extended partnership with InTouch Health, which develops telemedicine systems for providing remote health care.
The venture builds on an existing relationship that the companies announced last summer, under which the companies engaged in a development and licensing agreement.